Journal
REGULATORY TOXICOLOGY AND PHARMACOLOGY
Volume 89, Issue -, Pages 193-199Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.yrtph.2017.07.032
Keywords
Pharmacokinetics; Smoking; Cigarette; THS; Smoking urges; Nicotine gum; Menthol
Categories
Funding
- Philip Morris Products S.A.
Ask authors/readers for more resources
Two open-label randomized cross-over studies in Japanese smokers investigated the single-use nicotine pharmacokinetic profile of the Tobacco Heating System (THS) 2.2, cigarettes (CC) and nicotine replacement therapy (Gum). In each study, one on the regular and one on the menthol variants of the THS and CC, both using Gum as reference, 62 subjects were randomized to four sequences: Sequence 1: THS - CC (n = 22); Sequence 2: CC THS (n = 22); Sequence 3: THS Gum (n = 9); Sequence 4: Gum THS (n = 9). Plasma nicotine concentrations were measured in 16 blood samples collected over 24 h after single use. Maximal nicotine concentration (C-max) and area under the curve from start of product use to time of last quantifiable concentration (AUC(0-last)) were similar between THS and CC in both studies, with ratios varying from 88 to 104% for C-max and from 96 to 98% for AUC(0-last). Urge-to-smoke total scores were comparable between THS and CC. The THS nicotine pharmacokinetic profile was close to CC, with similar levels of urge-to-smoke. This suggests that THS can satisfy smokers and be a viable alternative to cigarettes for adult smokers who want to continue using tobacco. (C) 2017 The Authors. Published by Elsevier Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available